Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 7, 2012 - Issue 3
Submit an article Journal homepage
112
Views
9
CrossRef citations to date
0
Altmetric
Drug Profile

Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia

Johannes Häberle University Children's Hospital, Division of Metabolism, Children's Research Center, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland. [email protected]
Pages 263-271 | Published online: 10 Jan 2014

References

  • Bachmann C. Mechanisms of hyperammonemia. Clin. Chem. Lab. Med. 40(7), 653–662 (2002).
  • Bachmann C. Inherited hyperammonemias. In: Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases. Blau N, Duran M, Blaskovic ME, Gibson KM (Eds.). Springer, Berlin, Germany, 261–276 (2003).
  • Häberle J. Clinical practice: the management of hyperammonemia. Eur. J. Pediatr. 170(1), 21–34 (2011).
  • Häberle J. Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency. Ther. Clin. Risk Manag. 7, 327–332 (2011).
  • Bachmann C, Krähenbühl S, Colombo JP, Schubiger G, Jaggi KH, Tönz O. N-acetylglutamate synthetase deficiency: a disorder of ammonia detoxication. N. Engl. J. Med. 304(9), 543 (1981).
  • Caldovic L, Morizono H, Tuchman M. Mutations and polymorphisms in the human N-acetylglutamate synthase (NAGS) gene. Hum. Mutat. 28(8), 754–759 (2007).
  • Brusilow S, Horwich A. Urea cycle enzymes. In: The Metabolic & Molecular Bases of Inherited Disease (8th Edition). Scriver C, Beaudet A, Sly W, Valle D (Eds). McGraw-Hill, NY, USA, 1909–1963 (2001).
  • Ah Mew N, Caldovic L. N-acetylglutamate synthase deficiency: an insight into genetics, epidemiology, pathophysiology, and treatment. Appl. Clin. Genet. 4, 127–135 (2011).
  • Burlina AB, Bachmann C, Wermuth B et al. Partial N-acetylglutamate synthetase deficiency: a new case with uncontrollable movement disorders. J. Inherit. Metab. Dis. 15(3), 395–398 (1992).
  • Caldovic L, Morizono H, Panglao MG, Cheng SF, Packman S, Tuchman M. Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia. Hum. Genet. 112(4), 364–368 (2003).
  • Elpeleg O, Shaag A, Ben-Shalom E, Schmid T, Bachmann C. N-acetylglutamate synthase deficiency and the treatment of hyperammonemic encephalopathy. Ann. Neurol. 52(6), 845–849 (2002).
  • Heckmann M, Wermuth B, Häberle J, Koch HG, Gortner L, Kreuder JG. Misleading diagnosis of partial N-acetylglutamate synthase deficiency based on enzyme measurement corrected by mutation analysis. Acta Paediatr. 94(1), 121–124 (2005).
  • Schubiger G, Bachmann C, Barben P, Colombo JP, Tönz O, Schüpbach D. N-acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication. Eur. J. Pediatr. 150(5), 353–356 (1991).
  • Häberle J, Denecke J, Schmidt E, Koch HG. Diagnosis of N-acetylglutamate synthase deficiency by use of cultured fibroblasts and avoidance of nonsense-mediated mRNA decay. J. Inherit. Metab. Dis. 26(6), 601–605 (2003).
  • Häberle J, Koch HG. Genetic approach to prenatal diagnosis in urea cycle defects. Prenat. Diagn. 24(5), 378–383 (2004).
  • Nordenström A, Halldin M, Hallberg B, Alm J. A trial with N-carbamylglutamate may not detect all patients with NAGS deficiency and neonatal onset. J. Inherit. Metab. Dis. 30(3), 400 (2007).
  • Elpeleg ON, Colombo JP, Amir N, Bachmann C, Hurvitz H. Late-onset form of partial N-acetylglutamate synthetase deficiency. Eur. J. Pediatr. 149(9), 634–636 (1990).
  • Forget PP, van Oosterhout M, Bakker JA, Wermuth B, Vles JS, Spaapen LJ. Partial N-acetyl-glutamate synthetase deficiency masquerading as a valproic acid-induced Reye-like syndrome. Acta Paediatr. 88(12), 1409–1411 (1999).
  • Caldovic L, Morizono H, Panglao MG et al. Late onset N-acetylglutamate synthase deficiency caused by hypomorphic alleles. Hum. Mutat. 25(3), 293–298 (2005).
  • Heibel SK, Ah Mew N, Caldovic L, Daikhin Y, Yudkoff M, Tuchman M. N-carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy. Hum. Mutat. 32(10), 1153–1160 (2011).
  • Colombo JP. N-acetylglutamate synthetase (NAGS) deficiency. Adv. Exp. Med. Biol. 368, 135–143 (1994).
  • Plecko B, Erwa W, Wermuth B. Partial N-acetylglutamate synthetase deficiency in a 13-year-old girl: diagnosis and response to treatment with N-carbamylglutamate. Eur. J. Pediatr. 157(12), 996–998 (1998).
  • Caldovic L, Morizono H, Gracia Panglao M et al. Cloning and expression of the human N-acetylglutamate synthase gene. Biochem. Biophys. Res. Commun. 299(4), 581–586 (2002).
  • Häberle J, Schmidt E, Pauli S et al. Mutation analysis in patients with N-acetylglutamate synthase deficiency. Hum. Mutat. 21(6), 593–597 (2003).
  • Schmidt E, Nuoffer JM, Häberle J et al. Identification of novel mutations of the human N-acetylglutamate synthase gene and their functional investigation by expression studies. Biochim. Biophys. Acta 1740(1), 54–59 (2005).
  • Jones S, Reed CA, Vijay S, Walter JH, Morris AA. N-carbamylglutamate for neonatal hyperammonaemia in propionic acidaemia. J. Inherit. Metab. Dis. 31(Suppl. 2), S219–S222 (2008).
  • Schwahn BC, Pieterse L, Bisset WM, Galloway PG, Robinson PH. Biochemical efficacy of N-carbamylglutamate in neonatal severe hyperammonaemia due to propionic acidaemia. Eur. J. Pediatr. 169(1), 133–134 (2010).
  • Tuchman M, Caldovic L, Daikhin Y et al. N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers. Pediatr. Res. 64(2), 213–217 (2008).
  • Gebhardt B, Vlaho S, Fischer D, Sewell A, Böhles H. N-carbamylglutamate enhances ammonia detoxification in a patient with decompensated methylmalonic aciduria. Mol. Genet. Metab. 79(4), 303–304 (2003).
  • Kasapkara CS, Ezgu FS, Okur I, Tumer L, Biberoglu G, Hasanoglu A. N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia. Eur. J. Pediatr. 170(6), 799–801 (2011).
  • Aires CC, van Cruchten A, Ijlst L et al. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA. J. Hepatol. 55(2), 426–434 (2011).
  • Summar M. Current strategies for the management of neonatal urea cycle disorders. J. Pediatr. 138(1 Suppl.), S30–S39 (2001).
  • Summar M, Tuchman M. Proceedings of a consensus conference for the management of patients with urea cycle disorders. J. Pediatr. 138(1 Suppl.), S6–S10 (2001).
  • Häberle J, Boddaert N, Burlina A et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J. Rare Dis. (2012) (In Press).
  • Bachmann C. Hyperammonaemia: review of current treatment strategies. In: Pathophysiology and Management of Hyperammonemia. Bachmann C, Häberle J, Leonard JV (Eds). SPS Publications, Heilbronn, Germany, 157–173 (2006).
  • Feillet F, Leonard JV. Alternative pathway therapy for urea cycle disorders. J. Inherit. Metab. Dis. 21(Suppl. 1), 101–111 (1998).
  • Leonard JV, Morris AA. Urea cycle disorders. Semin. Neonatol. 7(1), 27–35 (2002).
  • Nassogne MC, Héron B, Touati G, Rabier D, Saudubray JM. Urea cycle defects: management and outcome. J. Inherit. Metab. Dis. 28(3), 407–414 (2005).
  • Bachmann C, Colombo JP, Jaggi K. N-acetylglutamate synthetase (NAGS) deficiency: diagnosis, clinical observations and treatment. Adv. Exp. Med. Biol. 153, 39–45 (1982).
  • Guffon N, Vianey-Saban C, Bourgeois J, Rabier D, Colombo JP, Guibaud P. A new neonatal case of N-acetylglutamate synthase deficiency treated by carbamylglutamate. J. Inherit. Metab. Dis. 18(1), 61–65 (1995).
  • Morris AA, Richmond SW, Oddie SJ, Pourfarzam M, Worthington V, Leonard JV. N-acetylglutamate synthetase deficiency: favourable experience with carbamylglutamate. J. Inherit. Metab. Dis. 21(8), 867–868 (1998).
  • Saheki T, Ohkubo T, Katsunuma T. Regulation of urea synthesis in rat liver. Increase in the concentrations of ornithine and acetylglutamate in rat liver in response to urea synthesis stimulated by the injection of an ammonium salt. J. Biochem. 84(6), 1423–1430 (1978).
  • Gessler P, Buchal P, Schwenk HU, Wermuth B. Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency. Eur. J. Pediatr. 169(2), 197–199 (2010).
  • Bélanger-Quintana A, Martínez-Pardo M, García MJ et al. Hyperammonaemia as a cause of psychosis in an adolescent. Eur. J. Pediatr. 162(11), 773–775 (2003).
  • Caldovic L, Ah Mew N, Shi D, Morizono H, Yudkoff M, Tuchman M. N-acetylglutamate synthase: structure, function and defects. Mol. Genet. Metab. 100(Suppl. 1), S13–S19 (2010).
  • Häussinger D. Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem. J. 267(2), 281–290 (1990).
  • Häussinger D. Liver glutamine metabolism. JPEN. J. Parenter. Enteral Nutr. 14(4 Suppl.), 56S–62S (1990).
  • Metzenberg RL, Marshall M, Cohen PP. Purification of carbamyl phosphate synthetase from frog liver. J. Biol. Chem. 233(1), 102–105 (1958).
  • Daniotti M, la Marca G, Fiorini P, Filippi L. New developments in the treatment of hyperammonemia: emerging use of carglumic acid. Int. J. Gen. Med. 4, 21–28 (2011).
  • Ah Mew N, McCarter R, Daikhin Y, Nissim I, Yudkoff M, Tuchman M. N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia. Pediatrics 126(1), e208–e214 (2010).
  • Filippi L, Gozzini E, Fiorini P, Malvagia S, la Marca G, Donati MA. N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria. Neonatology 97(3), 286–290 (2010).
  • Gebhardt B, Dittrich S, Parbel S, Vlaho S, Matsika O, Bohles H. N-carbamylglutamate protects patients with decompensated propionic aciduria from hyperammonaemia. J. Inherit. Metab. Dis. 28(2), 241–244 (2005).
  • Coude FX, Sweetman L, Nyhan WL. Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J. Clin. Invest. 64(6), 1544–1551 (1979).
  • Meijer AJ, Van Woerkom GM, Wanders RJ, Lof C. Transport of N-acetylglutamate in rat-liver mitochondria. Eur. J. Biochem. 124(2), 325–330 (1982).
  • Rubio V, Grisolia S. Human carbamoylphosphate synthetase I. Enzyme 26(5), 233–239 (1981).
  • Hall LM, Metzenberg RL, Cohen PP. Isolation and characterization of a naturally occurring cofactor of carbamyl phosphate biosynthesis. J. Biol. Chem. 230(2), 1013–1021 (1958).
  • Kim S, Paik WK, Cohen PP. Ammonia intoxication in rats: protection by N-carbamoyl-l-glutamate plus l-arginine. Proc. Natl Acad. Sci. USA 69(12), 3530–3533 (1972).
  • O'Connor JE, Jordá A, Grisolía S. Acute and chronic effects of carbamyl glutamate on blood urea and ammonia. Eur. J. Pediatr. 143(3), 196–197 (1985).
  • Grau E, Felipo V, Miñana MD, Grisolía S. Treatment of hyperammonemia with carbamylglutamate in rats. Hepatology 15(3), 446–448 (1992).
  • Hinnie J, Colombo JP, Wermuth B, Dryburgh FJ. N-acetylglutamate synthetase deficiency responding to carbamylglutamate. J. Inherit. Metab. Dis. 20(6), 839–840 (1997).
  • Caldovic L, Morizono H, Daikhin Y et al. Restoration of ureagenesis in N-acetylglutamate synthase deficiency by N-carbamylglutamate. J. Pediatr. 145(4), 552–554 (2004).
  • Guffon N, Gessler P, Galloway P et al. Treatment of NAGS deficiency: retrospective data on 23 patients treated with carglumic acid over 16 years (abstract). Mol. Genet. Metab. 102(3), 286–287 (2011).
  • Guffon N, Schiff M, Cheillan D, Wermuth B, Häberle J, Vianey-Saban C. Neonatal hyperammonemia: the N-carbamoyl-l-glutamic acid test. J. Pediatr. 147(2), 260–262 (2005).
  • Ah Mew N, Payan I, Daikhin Y et al. Effects of a single dose of N-carbamylglutamate on the rate of ureagenesis. Mol. Genet. Metab. 98(4), 325–330 (2009).
  • Lévesque S, Karalis A, Lambert M, Russell L. Outcome of propionic acidemia treated at presentation with N-carbamylglutamate (abstract). Mol. Genet. Metab. 99, 203 (2010).
  • Levrat V, Forest I, Fouilhoux A, Acquaviva C, Vianey-Saban C, Guffon N. Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia? Orphanet J. Rare Dis. 3, 2 (2008).
  • Valayannopoulos V, Geb S, Chakrapani A et al. Carglumic acid (NCG) as treatment of hyperammonemia episodes in organic acidemias/acidurias (OAS): a retrospective observational study in patients from Europe and Turkey (abstract). J. Inherit. Metab. Dis. 34, S146 (2011).
  • Ah Mew N, Daikhin E, Payan I et al. N-carbamylglutamate increases ureagenesis in patients with CPSI deficiency (abstract). Mol. Genet. Metab. 99, 207 (2010).
  • Pekkala S, Martínez AI, Barcelona B et al. Structural insight on the control of urea synthesis: identification of the binding site for N-acetyl-l-glutamate, the essential allosteric activator of mitochondrial carbamoyl phosphate synthetase. Biochem. J. 424(2), 211–220 (2009).
  • Pekkala S, Martínez AI, Barcelona B et al. Understanding carbamoyl-phosphate synthetase I (CPS1) deficiency by using expression studies and structure-based analysis. Hum. Mutat. 31(7), 801–808 (2010).
  • Nissim I, Horyn O, Nissim I et al. Down-regulation of hepatic urea synthesis by oxypurines: xanthine and uric acid inhibit N-acetylglutamate synthase. J. Biol. Chem. 286(25), 22055–22068 (2011).
  • Leonard JV, Richmond S. Pricing of orphan drugs. Lancet 373(9662), 462 (2009).
  • Häberle J. Diagnosis and treatment of urea cycle disorders. J. Pediatr. Sci. 3, e65–e74 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.